Ted Bosworth March 12, 2025 ORLANDO, FLA. — Janus kinase (JAK) inhibitors have revolutionized the treatment of alopecia areata (AA), and more drugs in this class are still in development for AA. However, a new therapy with a new mechanism of action also appeared to provide major hair regrowth with an effect that persists after […]
New Bifunctional Drug Shows Sustained Effect in Alopecia Areata Read More »
NEW YORK — Of the adjunctive treatments available for alopecia, the list of those supported by data is fairly short, but clinicians are inevitably asked about others, and it can be helpful to distinguish those that are at least benign when faced with patients ready to try anything, according to two experts. Outlining over-the-counter therapies
Over-the-Counter Adjunctive Alopecia Treatments: Consider Their Potential for Harm Read More »
PARIS — Long-term results from the ALLEGRO clinical trial program of Pfizer’s JAK inhibitor ritlecitinib for severe alopecia areata showed that complete scalp regrowth occurred in a good proportion of patients. Nearly one third (31.2%) of patients taking ritlecitinib over 3 years had complete scalp hair regrowth at least once, Brett King, MD, PhD, a dermatologist based in Fairfield,
Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.
✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866